METiS Therapeutics

METiS Therapeutics is a biotechnology company dedicated to advancing treatments across a broad range of disease areas by integrating drug discovery and delivery with artificial intelligence, machine learning, and quantum simulations. The METiS platform (AiTEM) combines state-of-the-art AI data-driven algorithms, mechanism-driven quantum mechanics, and molecular dynamics simulations to compute active pharmaceutical ingredient (API) properties, elucidate API targets and API-excipient interactions, and predict the chemical, physical, and pharmacokinetic properties of small molecules and nucleic acid therapies within specific microenvironments. This enables efficient lead optimization, candidate selection, and formulation design.